Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of proton pump inhibitors on the structural integrity of endoscopic sleeve gastroplasty
2024-517679-18-00Phase 4Authorised
- Sponsor
- Policlinico Gemelli
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of esomeprazole in obesity (2 arms), sponsored by Policlinico Gemelli. Planned start Dec 2024; status: authorised.
02
Drugs
esomeprazole
03
Conditions
obesity
Beyond the preview
Go deeper on 2024-517679-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517679-18-00.